Veille scientifique COVID-19

Veille scientifique COVID-19
Bulletin du 10/06/2021

Catégories


Pour consulter l'ensemble des articles par catégorie, en ordre décroissant de parution, cliquer sur un des liens suivants :

 

 

À ne pas manquer


BNT162b2 vaccine effectiveness in preventing asymptomatic infection with SARS-CoV-2 virus: a nationwide historical cohort study


Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19


Does reactogenicity after a second injection of the BNT162b2 vaccine predict spike IgG antibody levels in healthy Japanese subjects?


BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants


First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland


Delayed Large Local Reactions to mRNA Covid-19 Vaccines in Blacks, Indigenous Persons, and People of Color


Declined Antibody Responses to COVID-19 mRNA Vaccine within First Three Months


The importance of time post-vaccination in determining the decrease in vaccine efficacy against SARS-CoV-2 variants of concern


Highly-specific memory B cells generation after the 2nd dose of BNT162b2 vaccine compensate for the decline of serum antibodies and absence of mucosal IgA


BNT162b2 mRNA vaccinations in Israel: understanding the impact and improving the vaccination policies by redefining the immunized population


Genome-wide analysis in 756,646 individuals provides first genetic evidence that ACE2 expression influences COVID-19 risk and yi...


Possible future waves of SARS-CoV-2 infection generated by variants of concern with a range of characteristics


Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020-May 2021


Modelling the effect of an improved trace and isolate system in the wake of a highly transmissible Covid-19 variant with potential vaccine escape


The potential of SARS-CoV-2 antigen-detection tests in the screening of asymptomatic persons


The protective effect of SARS-CoV-2 antibodies in Scottish healthcare workers


Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccination


Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis


Increased household secondary attacks rates with Variant of Concern SARS-CoV-2 index cases


A model and predictions for COVID-19 considering population behavior and vaccination


Determining quarantine length and testing frequency for international border opening


SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama


Association between risk of VTE and mortality in patients with COVID-19


Preventing COVID-19 Transmission in Education Settings


Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19


Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study


SARS-CoV-2 emerging variants in Africa: view from Gabon


SARS-CoV-2 infection in pregnancy in Denmark - characteristics and outcomes after confirmed infection in pregnancy: a nationwide, prospective, population-based cohort study


SARS-CoV-2 seroprevalence in students and teachers: a longitudinal study from May to October 2020 in German secondary schools


Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection


© TOUS DROITS RÉSERVÉS 2018 - Association des gens d'affaires et professionels